SC 13G/A | 2024-02-14 | BAKER BROS. ADVISORS LP | Immatics N.V. | 5,838,853 | 6.9% | EDGAR |
SC 13G/A | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Immatics N.V. | 6,352,929 | 7.5% | EDGAR |
SC 13G/A | 2024-02-07 | ATHOS KG | Immatics N.V. | 4,911,278 | 5.8% | EDGAR |
SC 13G/A | 2024-02-07 | ATHOS KG | Immatics N.V. | 4,911,278 | 4.8% | EDGAR |
SC 13G | 2023-08-16 | ATHOS KG | Immatics N.V. | 4,911,778 | 6.4% | EDGAR |
SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | Immatics N.V. | 5,187,081 | 6.8% | EDGAR |
SC 13G/A | 2023-02-14 | Nantahala Capital Management, LLC | Immatics N.V. | 3,734,628 | 4.9% | EDGAR |
SC 13G/A | 2023-02-10 | dievini Hopp BioTech holding GmbH & Co KG | Immatics N.V. | 17,202,356 | 26.2% | EDGAR |
SC 13G | 2023-02-07 | WELLINGTON MANAGEMENT GROUP LLP | Immatics N.V. | 5,957,794 | 7.8% | EDGAR |
SC 13G | 2022-02-14 | Nantahala Capital Management, LLC | Immatics N.V. | 3,990,128 | 6.2% | EDGAR |
SC 13G | 2022-02-14 | BAKER BROS. ADVISORS LP | Immatics N.V. | 4,423,731 | 7.0% | EDGAR |
SC 13G/A | 2022-02-11 | dievini Hopp BioTech holding GmbH & Co KG | Immatics N.V. | 17,202,355 | 27.3% | EDGAR |
SC 13G | 2021-02-16 | ARYA SCIENCES HOLDINGS | Immatics N.V. | 3,503,750 | 5.6% | EDGAR |
SC 13G | 2021-02-12 | dievini Hopp BioTech holding GmbH & Co KG | Immatics N.V. | 16,476,073 | 26.2% | EDGAR |
SC 13G/A | 2020-08-10 | Nantahala Capital Management, LLC | Immatics N.V. | 2,360,742 | 3.7% | EDGAR |